Evidence map›Paper›PMID 40273184›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2025

Click-Functionalized Cyanine Fluorogenic Dimers for Improved Detection of GPCRs: Application to Imaging of ApelinR in Living Cells.

Océane Florès, Yann Berthomé, Lucille Weiss, Sarah Griesbaum-Dubourg, Stéphanie Riché, Patrick Wagner, Christel Valencia, Pascal Villa, Andrey S Klymchenko, Julie Karpenko and 1 more

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Océane FlorèsLaboratoire d'Innovation Thérapeutique, UMR 7200 CNRS, Université de Strasbourg, Institut du Médicament de Strasbourg, Strasbourg, F-67000, France.
Yann BerthoméLaboratoire d'Innovation Thérapeutique, UMR 7200 CNRS, Université de Strasbourg, Institut du Médicament de Strasbourg, Strasbourg, F-67000, France.
Lucille WeissLaboratoire d'Innovation Thérapeutique, UMR 7200 CNRS, Université de Strasbourg, Institut du Médicament de Strasbourg, Strasbourg, F-67000, France.
Sarah Griesbaum-DubourgLaboratoire d'Innovation Thérapeutique, UMR 7200 CNRS, Université de Strasbourg, Institut du Médicament de Strasbourg, Strasbourg, F-67000, France.
Stéphanie RichéLaboratoire d'Innovation Thérapeutique, UMR 7200 CNRS, Université de Strasbourg, Institut du Médicament de Strasbourg, Strasbourg, F-67000, France.
Patrick WagnerLaboratoire d'Innovation Thérapeutique, UMR 7200 CNRS, Université de Strasbourg, Institut du Médicament de Strasbourg, Strasbourg, F-67000, France.
Christel ValenciaPCBIS Plateforme de chimie biologie intégrative de Strasbourg, UAR 3286 CNRS, Université de Strasbourg, Strasbourg, F-67000, France.
Pascal VillaPCBIS Plateforme de chimie biologie intégrative de Strasbourg, UAR 3286 CNRS, Université de Strasbourg, Strasbourg, F-67000, France.
Andrey S KlymchenkoLaboratoire de Bioimagerie et Pathologies, UMR 7021 CNRS, Université de Strasbourg, Strasbourg, F-67000, France.
Julie KarpenkoLaboratoire d'Innovation Thérapeutique, UMR 7200 CNRS, Université de Strasbourg, Institut du Médicament de Strasbourg, Strasbourg, F-67000, France.
Dominique BonnetLaboratoire d'Innovation Thérapeutique, UMR 7200 CNRS, Université de Strasbourg, Institut du Médicament de Strasbourg, Strasbourg, F-67000, France.

Funding

Agence Nationale de la Recherche ANR-OCHRE-19-CE14-0035Graduate School of Pain Euridol Programmed'investissementd'Avenir,ANR-17-EURE-0022Programme santé du mécénat des Mutuelles AXASATT Conectus AlsaceStrasbourg Drug Discovery and Development Institute (IMS) IdexUnistra(ANR-20-SFRI-0012)Strasbourg Drug Discovery and Development Institute (IMS) SFRI-STRAT'US(ANR-10-IDEX-0002)
6 · The paper itself

Abstract

Fluorogenic dimers enable background-free imaging of biological targets under wash-free conditions owing to a strong fluorescence enhancement in the apolar cell microenvironment. However, it is crucial that the imaging probe interacts solely with the target receptor to avoid nonspecific interactions and ensure detection with a high signal-to-noise ratio. Herein, we describe a convenient and rapid approach for the synthesis of various functionalized cyanine dyes by click chemistry allowing the fine-tuning of the physicochemical and fluorogenic properties of the dimers. A structure-interaction relationship study was conducted for the fluorogenic dimers in the presence of bovine serum albumin (BSA) and liposomes as models of serum proteins and cell membranes. We identified d─Cy─E which combined the lowest nonspecific interactions with the optimal fluorescence turn-on properties. By conjugating d─Cy─E to a peptide ligand of the apelin GPCR, we developed Ap─d─Cy─E, the first fluorescent turn-on probe for the background-free imaging of this receptor in living cells.

Indexed as

Apelin ReceptorsCarbocyaninesFluorescent DyesReceptors, G-Protein-CoupledAnimalsCattleClick ChemistryDimerizationHumansLiposomesSerum Albumin, BovineApelin ReceptorsCarbocyaninesFluorescent DyesLiposomesReceptors, G-Protein-CoupledSerum Albumin, Bovineapelinbioimagingfluorescent probefluorogenic dimersGPCR

Identifiers

PMID40273184
PMCPMC12144865

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.